Danaher Corporation’s Post

An underrated 👀 but essential factor in understanding why #Danaher operating companies like #SCIEX, #Cytiva and #Phenomenex are superior vendors? Their exceptional financial stability. 💰✨ While investors love 😍 talking about the Danaher Business System's great management practices, customers can rely on these companies because: 1) They are disciplined and financially strong 💪 across Danaher's portfolio, including Phenomenex. Consistent profits, robust cash flows, and healthy balance sheets enable reliable operations. 2) There's a commitment to high product quality. 👌 The Business System drives continuous improvement in manufacturing and rigorous quality control. 3) They demonstrate long-term viability as vendors. 🏆 Danaher's sustainable growth, operational excellence, and smart investments mean companies like SCIEX and Phenomenex will remain dependable partners. Through prudent management of the Danaher Business System, these operating companies maintain financial fortitude. 🔐 Customers can trust that #SCIEX, #Phenomenex and others will consistently deliver top-notch products and services! Their stability is a crucial 🥇 advantage making them more reliable vendors. Don't underestimate the power of a rock-solid vendor! 💎

Don't let fragmented workflows slow down your progress. At Danaher, we leverage the solutions from our best in class global life science brands to drive quantifiable outcomes. Our unified approach to next generation therapeutic development ensures smooth transitions between stages, saving you time and resources. Experience the difference. Discover and innovate at the speed of life! #danaher #danaherls #speedoflife

#DrugDiscovery techniques are as varied as the therapeutics produced that help save so many lives. And our Asia Flow Chemistry System is the forefront of innovative solutions for precise, rapid and cost-effective synthesis. Find out how our award-winning products are helping to create consistent #chemistry: https://ow.ly/bFzJ50Qkv9I #FlowChemistry

𝐓𝐡𝐞 𝐅𝐮𝐭𝐮𝐫𝐞 𝐨𝐟 𝐌𝐞𝐝𝐢𝐜𝐢𝐧𝐞: 𝐇𝐨𝐰 𝐂𝐞𝐥𝐥 𝐓𝐡𝐞𝐫𝐚𝐩𝐲 𝐓𝐞𝐜𝐡𝐧𝐨𝐥𝐨𝐠𝐢𝐞𝐬 𝐚𝐫𝐞 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧𝐢𝐳𝐢𝐧𝐠 𝐇𝐞𝐚𝐥𝐭𝐡𝐜𝐚𝐫𝐞 𝑫𝒐𝒘𝒏𝒍𝒐𝒂𝒅 𝑷𝑫𝑭 𝑩𝒓𝒐𝒄𝒉𝒖𝒓𝒆 @ bit.ly/4cuyFik The global #cell_therapy_technologies market in terms of revenue is poised to reach $7.8 billion by 2028, growing at a CAGR of 13.3% from 2023 to 2028. Thermo Fisher Scientific, Merck KGaA, Darmstadt, Germany, Danaher Corporation, Becton, Dickinson and Company, Lonza, Sartorius #celltherapy #celltherapeutics #regenerativemedicine #stemcellresearch #biotechnology #healthcareinnovation #precisionmedicine 

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dwhPYC8T The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck KGaA, Darmstadt, Germany Danaher Corporation Revvity TECAN GROUP AG-REG Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience . #highthroughputscreening #drugdiscovery #biotech #hts #pharmatech

This article may change the way you approach the #drugdevelopment process. https://lnkd.in/ggwxmz9r It was also cross referenced at #pharmaceuticalonline, #outsourcedpharma, and #drugdeliveryleader.

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dtphnyZW The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity, Tecan Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BRAND GMBH + CO KG BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #hts #screeningtechnology #biotechnology

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/dxtRJrNe The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity, Tecan Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Aurora Biomed Inc. Gilson BRAND GMBH + CO KG BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #hts #screeningtechnology #biotechnology

In a rapidly evolving #biotech landscape, strategic partnerships are paramount. Recent congressional scrutiny surrounding a major firm's involvement in U.S. pharmaceuticals underscores the importance of choosing the right #laboratory partner. As lawmakers raise national security concerns and seek to disengage from certain entities, it's crucial to recognize the potential impact on drug and device development pipelines. https://lnkd.in/g2XDBvsw For our part, US-based iuvo Bioscience continues to serve the medical device and pharmaceutical industry through exquisite science and providing exceptional service. Our commitment to excellence ensures that projects are not only propelled forward but also shielded from external uncertainties. By choosing iuvo as your laboratory partner, you gain access to a team dedicated to upholding the highest standards of quality and compliance. As the biotech industry navigates shifting dynamics, iuvo BioScience remains steadfast in our mission to empower innovation. Let's collaborate to drive breakthrough discoveries forward while safeguarding the integrity of your projects. Reach out today and discover the iuvo difference! #BiotechInnovation #DrugDevelopment #Partnership #Trust #Innovation #iuvoBioscience; Ben Burton; David Kudla, MBA; Shannon Stoddard; Scott Barnhill; BioSpace; Sanjeev Ganatra; #preclinicalresearch; #clinicalresearch; Biotechnology Innovation Organization; Empire State Development; NewYorkBIO https://lnkd.in/gbviMKKt

High-Throughput Screening (HTS) Market worth $50.2 billion by 2029 Download PDF Brochure:-https://lnkd.in/d56rtKJb The size of global high throughput screening market in terms of revenue was estimated to be worth $28.8 billion in 2024 and is poised to reach $50.2 billion by 2029, growing at a CAGR of 11.8% from 2024 to 2029. 𝐓𝐡𝐞 𝐜𝐨𝐦𝐩𝐚𝐧𝐢𝐞𝐬 𝐟𝐞𝐚𝐭𝐮𝐫𝐞𝐝 𝐢𝐧 𝐭𝐡𝐢𝐬 𝐫𝐞𝐩𝐨𝐫𝐭 𝐢𝐧𝐜𝐥𝐮𝐝𝐞 Thermo Fisher Scientific Agilent Technologies, Merck Danaher Corporation Revvity, Tecan Bio-Rad Laboratories, Corning Incorporated Mettler-Toledo International, Inc Lonza Waters Corporation Sartorius Eppendorf Porvair plc Greiner AG & Co KG Charles River Laboratories Eurofins Scientific Finland Oy Hamilton Company Gilson BRAND GMBH + CO KG BMG LABTECH DIANA Biotechnologies, Creative Biolabs. HighRes Biosolutions. Biomat Srl | Coated 96 Well Plates for ELISA & other Immunoassays & PCR Tubes and Plates, Axxam Sygnature Discovery Crown Bioscience #highthroughputscreening #drugdiscovery #hts #biotechinnovation #pharmaresearch